PharmaSafe at ICPE 2022!

A team of the PharmaSafe group traveled to Copenhagen to join the 38th International Conference on PharmacoEpidemiology (ICPE 2022).

We were excited to listen to cutting-edge research on “Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community”. The team contributed with three oral presentations and twelve posters, met collaboration partners from ongoing international projects, such as IMI-ConcePTION and CONSIGN, and participated in the Special Interest Group Meeting on Medication in Pregnancy and Lactation (MiPal). 

Image may contain: Product, Technology, Projection screen, Display device, Electronic device.
We had three talks and twelve poster presentations during the ICPE 2022 conference. Photos: private.
We enjoyed the conference, meeting collaborators and having fun at the Congress Party. Photos: private.

Organization of one symposium with an oral presentation

Hedvig Nordeng: Meeting the Need for Research on Drug Safety During Lactation: An Overview of Approaches – symposium on Drug Safety During Lactation Symposium

Oral presentations

Angela Lupattelli: Association of Prenatal Antidepressant Exposure with Trajectories and Acceleration of Body Mass Index in Children from 6 Week to 8 Years of Age

Nhung Thi Hong Trinh: Antidepressant Treatment in Pregnancy and Maternal Mental Health in the Postpartum Year: A Danish Registry Linkage Study in Pregnant Women with Obsessive‐compulsive Disorder

Posters

Angela Lupattelli et al.: Antidepressant Continuation and Adherence in Pregnancy and Risk of Antenatal Hospital Admission for Depression and/or Anxiety – Selected for Spotlight Poster Session

Eimir Hurley et al.: COVID-19 Infection and Medication Use in Pregnancy (CONSIGN) – A Multinational Drug Utilisation Study Using Linked Healthcare Data – Selected for Spotlight Poster Session

Nhung Trinh et al.: Association Between Antidepressant Use Patterns on The Long-Term Trajectories of Depressive and Anxiety Symptoms and Health-Related Quality of Life

Nhung Trinh et al.: Postpartum Episode of Eating, Mood, or Anxiety Disorder in Women with Eating Disorders Who Continue or Discontinue Antidepressant Treatment in Pregnancy

Angela Lupattelli et al.Decisional Conflicts About Antidepressant Treatment in Pregnant Women in Norway

Angela Lupattelli et al.Prenatal Exposure to Antidepressants and Risk of Overweight and Obesity in Offspring at Age 8 Years

Fatima Tauqeer et al.: Barriers and Enablers of Decision-Making Considering Use of Antidepressants – A Mixed-Method Study Among Pregnant and Postpartum Women with a Mental Illness

Ugochinyere Vivian Ukah et al.: Trends in Cardiovascular Medication Prescription Before and During the COVID-19 Pandemic

Mollie Wood et al.: Methodologic Considerations for Emulating Target Trial for Discontinuation of Antidepressant Treatment in Pregnancy

Co-authoring posters

Hedvig Nordeng and Eimir Hurley: COVID-19 Related Drug Utilization Study in Pregnancy – The COVI-Preg Cohort

Hedvig Nordeng and Eimir Hurley: Extracting Pregnancies from Heterogeneous Data Sources in Europe: A Novel Algorithm in The Conception Project

Angela Lupatelli: VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results

Published Aug. 31, 2022 5:49 PM - Last modified Sep. 4, 2022 1:19 PM